Tagged Articles

insulin therapy 2 articles

Study links insulin therapy to bladder cancer deaths in diabetics

Type 2 diabetics on insulin therapy are more likely to die from bladder cancer than those using other treatments, a new study suggests. Researchers with the Department of Internal Medicine at the National Taiwan University College of Medicine in Taipei, followed more than 86,000 patients with type 2 diabetes aged 25 or older from 1995 through 2006 for bladder cancer deaths. They concluded that patients who used insulin to keep their blood sugar levels in check were nearly twice as likely to die from bladder cancer compared to those who did not use insulin. Patients who used insulin and who ... Read More

Makers of inhaled insulin treatment for type 2 diabetics hope to apply for FDA approval

Afrezza, a novel, inhaled mealtime insulin therapy showed encouraging results in reducing long-term blood sugar levels in type 2 diabetics during two late-stage clinical studies, drug developer MannKind Corp. announced last week. Afrezza was pitted against the widely used generic metformin in type 2 diabetes patients during clinical trials, where data showed it worked better at long-term blood sugar reductions. It also performed well compared to another insulin treatment in type 1 diabetics. Afrezza is a fast-acting insulin powder that comes in single-use cartridges. The powder is delivered through an inhaler called Dreamboat. MannKind said that changes in lung function ... Read More